We found that loss of TET2 indeed leads to increased mRNA stability of urea cycle enzymes in tumor cells (Supplementary Fig. S5a, b) and mouse primary liver (Fig. 4a) and lung cells (Fig. 4b) when the de novo transcription has been blocked. Here, TET2 is linked to neoplasm.